Adjunctive Pharmacotherapy for Major Depressive Disorder with Anxiety Symptoms: from Monoamines to Recent Clinical Evidence.

McIntyre RS, Kato M, Thase ME, Therrien F, Marrache AM, Ikehara K, Ardic F, Boucher M.

Open source

DOI
10.1007/s40263-026-01315-7
Published
2026-07-28
Container
CNS Drugs
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40263-026-01315-7,
  title = {Adjunctive Pharmacotherapy for Major Depressive Disorder with Anxiety Symptoms: from Monoamines to Recent Clinical Evidence.},
  author = {McIntyre RS and  Kato M and  Thase ME and  Therrien F and  Marrache AM and  Ikehara K and  Ardic F and  Boucher M.},
  year = {2026},
  journal = {CNS Drugs},
  doi = {10.1007/s40263-026-01315-7},
  url = {https://doi.org/10.1007/s40263-026-01315-7}
}

RIS

TY  - JOUR
TI  - Adjunctive Pharmacotherapy for Major Depressive Disorder with Anxiety Symptoms: from Monoamines to Recent Clinical Evidence.
AU  - McIntyre RS
AU  -  Kato M
AU  -  Thase ME
AU  -  Therrien F
AU  -  Marrache AM
AU  -  Ikehara K
AU  -  Ardic F
AU  -  Boucher M.
PY  - 2026
JO  - CNS Drugs
DO  - 10.1007/s40263-026-01315-7
UR  - https://doi.org/10.1007/s40263-026-01315-7
ER  - 

APA

RS, M., M, K., ME, T., F, T., AM, M., K, I., F, A., & M., B. (2026). Adjunctive Pharmacotherapy for Major Depressive Disorder with Anxiety Symptoms: from Monoamines to Recent Clinical Evidence.. CNS Drugs. https://doi.org/10.1007/s40263-026-01315-7

Source records